McIntyre, Freedman & Flynn Investment Advisers’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
McIntyre, Freedman & Flynn Investment Advisers's MDT Position: Q2 2026 in Review
McIntyre, Freedman & Flynn Investment Advisers increased its Medtronic (MDT) stake by 0.05% in Q2 2026, buying an estimated $968 and bringing the position to 22,517 shares worth $1.76M. The position accounts for 1.06% of the portfolio, ranked #32.
McIntyre, Freedman & Flynn Investment Advisers first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.78M in Q2 2023. 1,667 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- McIntyre, Freedman & Flynn Investment Advisers held 22,517 shares of Medtronic worth $1.76M as of Q2 2026.
- McIntyre, Freedman & Flynn Investment Advisers bought 12 Medtronic shares in Q2 2026, an estimated $968.
- Medtronic made up 1.06% of McIntyre, Freedman & Flynn Investment Advisers's portfolio in Q2 2026, its #32 holding.
- McIntyre, Freedman & Flynn Investment Advisers first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
- McIntyre, Freedman & Flynn Investment Advisers's Medtronic position peaked at $2.78M in Q2 2023.
- 1,667 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on McIntyre, Freedman & Flynn Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.